OT - Record pace of drug approvals

http://www.startribune.com/record-pace-of-drug-approvals-prompts-cheers-from-patients-warnings-from-advocates/566852482/

Read this in morning paper, no telling what might happen when big money flows in this direction. Sometimes I think academia spends a lot of time looking in the rear view mirror (ie countless prostate treatment longevity studies) whereas companies tend to look forward and focus on the home runs such as cures. There is a good and bad to each approach but having faster approvals will be a great incentive for companies to push the envelope.
Potential issues of safety always exist when new drugs are approved, even before this 'faster pace" of approvals took place. Think Celebrex. This was years ago, and only after extensive use, was it discovered that there were health risks associated with the drug.

I think in the case of life threatening diseases, which is where the focus is, and especially cancer, most patients would say the risk is worth the speed
I am not a doctor, just another guy without a prostate
Dx Age 64 Nov 2014, PSA 4.3
BX 3 of 12 cores positive original pathology G6
RALP with Dr Ash Tewari Jan 6, 2015
Post surgical pathology G7 (3+4), - ECE, - Margins, -LN, -SV (+ frozen section apex converted to negative)
PSA @ 6 weeks 2/15, .<02, remained <0.02 until January 2017, .02, repeat Feb 2017, still .02. May 2017-.033, August 2017- .033 November .046, March 2018 .060. June 2018 .068, July 2018 - .082, August 2018, .078, August 2018 - .08 Start ADT. Sept 2018 Start SRT
Sept 2018 thru November 2018 – T = 4, PSA = <.05
Decipher test, low risk, .37 score
My story.... tinyurl.com/qgyu3xq
I agree with the expedited approval for drugs that have promise for people facing dire situations. Having it bogged down in a bureaucracy for who knows how long is really tough for someone who has nothing to lose. I think I would be willing to chance a "bad reaction" to a new drug if all I had to look forward to was a few months of a hard decline preceding imminent death.
Part I 2015, Age 54
PSA: 20.8 Bx: All cores G7 (4+3)
RALP & Adjuvant RT
Pathology: G8 (4+4)+5
PSA nadir: 0.1, steady increase until 2019: 64.13

Part II 2019
Lupron/Xtandi, PSA: <0.02
Today's approval
is tomorrow's recall
I'll be in the shop.
Age 59, 52 at DX
PSA:
4.2 10/11, 1.9 6/12, 1.2 12/12, 1.0 5/13, .6 11/13,
.7 5/14, .5 10/14, .5 4/15, .3 10/15, .3 4/16, .4 10/16, .4 5/17, .3 10/17 .3 4/18, .4 11/18
G 3+4
Stage T1C
2 out of 14 cores positive
Treatment IGRT - 2/2012